Research on garlic's antimicrobial properties in the context of SARS-CoV-2 presents a mixed picture depending on the type of evidence examined. In laboratory cell culture work, studies indicate that allicin, a sulfur-containing compound derived from garlic, can inhibit viral replication in both monkey kidney and human lung cells and appears to partially reverse infection-associated changes in cellular proteins, suggesting a possible protective mechanism at the cellular level. However, a large observational study involving over a million participants found no meaningful association between regular garlic consumption and a reduced likelihood of testing positive for SARS-CoV-2 in real-world conditions. The available evidence is limited to one cell-based study and one observational study, neither of which can establish cause and effect, and no randomized controlled trials have been conducted to test garlic's antimicrobial effects in humans, leaving significant uncertainty about whether laboratory findings translate to practical benefit.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Dietary supplements during the COVID-19 pandemic: insights from 1.4M users of... | Other | 2020 | — | 90 |
| Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host resp... | Other | 2021 | Supports | 85 |